- Exchange: Stuttgart
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Biostar Pharmaceuticals Inc
+ Add to Watchlist7BNA:GR
0.596 EUR 0.005 0.83%As of 03:03:07 ET on 05/23/2013.
Snapshot for Biostar Pharmaceuticals Inc (7BNA)
| Open: | 0.558 | Day's Range: | 0.558 - 0.596 | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 0.601 | 52wk Range: | 0.451 - 1.481 | 1-Yr Rtn: | -39.92% |
Key Statistics for 7BNA
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2011) | - |
| Relative P/E vs. DAX | - |
| Earnings Per Share (ttm) | - |
| Est. EPS (12/2011) | - |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 503 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/14/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 7BNA
Company Profile & Key Executives for 7BNA
Biostar Pharmaceuticals Inc. is a holding company. The Company, through its subsidiary, develops, manufactures and markets pharmaceutical and medical nutrient products for a variety of diseases and conditions.
| Ronghua WangChairman/President/CEO | Zibing Pan "Zack"Chief Financial Officer |
| Zhenghong WangChief Operating Officer | Shuang GongSecretary |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
7BNA News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page